Fund Holdings — First Turn Management, LLC

Total Portfolio Value:
$631.61M
Total Bought:
$220.02M
Total Sold:
$230.98M
Net Transaction:
-$10.96M
Notable People:
Lisa Gable Wheatley, Tracy Austin Murphy, Stephen Allyn Rosetta
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc252,276359,114+106,838$19.14M$36.74M5.82%+$17.60M
argenx SEADR(ARGX)79,97854,440-25,538$34.39M$29.51M4.67%-$4.88M
Insmed Incorporated(INSM)323,360356,451+33,091$21.67M$26.02M4.12%+$4.36M
Mirum Pharmaceuticals, Inc.(MIRM)703,398647,611-55,787$24.05M$25.26M4.00%+$1.21M
Vaxcyte, Inc.(PCVX)260,281211,985-48,296$19.65M$24.22M3.84%+$4.57M
Axsome Therapeutics, Inc.(AXSM)337,246255,294-81,952$27.15M$22.94M3.63%-$4.21M
Syndax Pharmaceuticals, Inc.(SNDX)640,3891,187,165+546,776$13.15M$22.85M3.62%+$9.71M
Ascendis Pharma A/SADR(ASND)186,581150,593-35,988$25.45M$22.49M3.56%-$2.96M
Natera, Inc.(NTRA)0155,650+155,650$0$19.76M3.13%+$19.76M
Intra-Cellular Therapies Inc347,343254,800-92,543$23.79M$18.64M2.95%-$5.15M
Crinetics Pharmaceuticals In369,302353,376-15,926$16.54M$18.06M2.86%+$1.52M
TransMedics Group, Inc.(TMDX)139,780114,247-25,533$21.05M$17.94M2.84%-$3.12M
Arcellx Inc
COMMON STOCK
0214,298+214,298$0$17.90M2.83%+$17.90M
Blueprint Medicines Corp184,901178,929-5,972$19.93M$16.55M2.62%-$3.38M
Verona Pharma PlcADS0572,928+572,928$0$16.48M2.61%+$16.48M
Vertex Pharmaceuticals Incorporated(VRTX)50,69235,222-15,470$23.76M$16.38M2.59%-$7.38M
Biohaven Ltd.(BHVN)366,019315,816-50,203$12.70M$15.78M2.50%+$3.08M
Establishment Labs Holdings Inc.(ESTA)369,980357,003-12,977$16.81M$15.45M2.45%-$1.36M
Merus N V321,906308,014-13,892$19.05M$15.39M2.44%-$3.66M
ORIC Pharmaceuticals, Inc.(ORIC)1,515,9601,451,037-64,923$10.72M$14.87M2.35%+$4.16M
Intuitive Surgical, Inc.(ISRG)41,90130,254-11,647$18.64M$14.86M2.35%-$3.78M
Harrow, Inc.(HROW)0326,582+326,582$0$14.68M2.32%+$14.68M
Vera Therapeutics, Inc.CL A(VERA)212,944326,494+113,550$7.70M$14.43M2.28%+$6.73M
Bicara Therapeutics Inc0562,391+562,391$0$14.32M2.27%+$14.32M
Geron Corporation(GERN)03,124,967+3,124,967$0$14.19M2.25%+$14.19M
Enliven Therapeutics Inc413,243535,092+121,849$9.66M$13.67M2.16%+$4.01M
Adma Biologics Inc0664,985+664,985$0$13.29M2.10%+$13.29M
Day One Biopharmaceuticals I
COM
0947,878+947,878$0$13.20M2.09%+$13.20M
Repligen Corporation(RGEN)088,714+88,714$0$13.20M2.09%+$13.20M
Xenon Pharmaceuticals Inc.(XENE)339,876325,218-14,658$13.25M$12.80M2.03%-$447.9K
Glaukos Corporation(GKOS)096,097+96,097$0$12.52M1.98%+$12.52M
Krystal Biotech, Inc.(KRYS)109,22267,942-41,280$20.06M$12.37M1.96%-$7.69M
Cytokinetics, Incorporated(CYTK)293,318223,147-70,171$15.89M$11.78M1.87%-$4.11M
Rocket Pharmaceuticals, Inc.(RCKT)560,989621,306+60,317$12.08M$11.48M1.82%-$602.6K
BridgeBio Pharma, Inc.(BBIO)0399,781+399,781$0$10.18M1.61%+$10.18M
Relay Therapeutics, Inc.(RLAY)01,226,354+1,226,354$0$8.68M1.37%+$8.68M
ARS Pharmaceuticals, Inc.(SPRY)0593,291+593,291$0$8.60M1.36%+$8.60M
Kalvista Pharmaceuticals Inc1,059,540355,000-704,540$12.48M$4.11M0.65%-$8.37M
Alphatec Holdings, Inc.(ATEC)1,360,4100-1,360,410$14.22M$0—-$14.22M
Apogee Therapeutics Inc318,3270-318,327$12.53M$0—-$12.53M
DexCom, Inc.(DXCM)160,0960-160,096$18.15M$0—-$18.15M
Disc Medicine, Inc.(IRON)138,9070-138,907$6.26M$0—-$6.26M
IDEAYA Biosciences, Inc.(IDYA)397,7820-397,782$13.97M$0—-$13.97M
Immunocore Holdings plcADS(IMCR)291,0860-291,086$9.86M$0—-$9.86M
Immunovant, Inc.(IMVT)695,4280-695,428$18.36M$0—-$18.36M
Revolution Medicines, Inc.(RVMD)329,5190-329,519$12.79M$0—-$12.79M
Sarepta Therapeutics, Inc.(SRPT)181,6690-181,669$28.70M$0—-$28.70M
Silence Therapeutics plcADS(SLN)537,3380-537,338$10.21M$0—-$10.21M
Spyre Therapeutics, Inc.(SYRE)464,4350-464,435$10.92M$0—-$10.92M
Page 1 of 1
First Turn Management, LLC — 13F Holdings — Q3 2024 | TickerTrail